Previous Article | Next Article 
Infection and Immunity, November 2000, p. 6398-6401, Vol. 68, No. 11
Department of
Medicine1 and Department of Veterans
Affairs Medical Center,2 The University
of Iowa, Iowa City, Iowa, and the Medical Intensive Care Unit, Cochin
University Hospital, Paris, France3
Received 12 June 2000/Returned for modification 11 August
2000/Accepted 21 August 2000
The toll-like receptor 2 (TLR2) has gained importance as a major
mammalian receptor for lipoproteins derived from the cell wall of a
variety of bacteria, such as Borrelia burgdorferi,
Treponema pallidum, and Mycoplasma fermentans.
We were interested in identifying mutations in the TLR2 gene that might
prove to be associated with altered susceptibility to septic shock. We
performed a mutation screen of the TLR2 gene using single-stranded
conformational polymorphism in 110 normal, healthy study subjects and
detected an Arg753Gln mutation in three individuals. No other missense
mutations were detected in the TLR2 open reading frame. Functional
studies demonstrate that the Arg753Gln polymorphism, in comparison to
the wild-type TLR2 gene, is significantly less responsive to bacterial
peptides derived from B. burgdorferi and T. pallidum. In a septic shock population, the Arg753Gln TLR2
polymorphism occurred in 2 out of 91 septic patients. More importantly,
both of the subjects with the TLR2 Arg753Gln polymorphism had
staphylococcal infections. These findings suggest that a mutation in
the TLR2 gene may predispose individuals to life-threatening bacterial infections.
Microbial pathogens are a major
health concern worldwide. Invasion of the host by microbial pathogens
causes the activation of the innate immune response, which acts as a
first line of defense against pathogenic bacteria. The innate immune
response triggers a sequence of events that results in the production
and secretion of cytokines and chemokines, activation of macrophages
and monocytes, and in some cases initiation of adaptive immunity
(10).
The toll receptors appear to be very important in initiating the innate
immune response. C3H/HeJ mice which have a mutation in the toll-like
receptor 4 (TLR4) gene (Pro712His) and C57BL6/10ScCr mice which have a
deletion of TLR4 are both hyporesponsive to lipopolysaccharide (LPS)
(12). The TLR4 mutation in C3H/HeJ mice was the first direct
proof for identifying TLR4 as a major LPS receptor in mammals.
Subsequently TLR4 This line of reasoning led us to hypothesize that mutations in TLR2
could be associated with a diminished response to gram-positive lipoproteins and place individuals at higher risk of gram-positive infections. We have identified a missense mutation that occurs in about
3% of people tested and results in an arginine to glutamine substitution at residue 753 of the human TLR2 gene. Transfection of
293T cells with either wild-type or mutant (Arg753Gln) TLR2 shows that
the response to LPS 0111.B4 is unaffected by the mutation, while the
response to different bacterial lipoproteins is reduced in the TLR2
Arg753Gln mutant compared to wild-type TLR2 cells. When a population of
septic shock patients and healthy blood donor controls was analyzed, it
was found that the TLR2 mutation occurred at the same frequency in both
groups. However, two patients carrying the TLR2 Arg753Gln mutation both
suffered from gram-positive infections. These results suggest that the
TLR2 mutation Arg753Gln could be a risk factor for developing septic
shock after infection by gram-positive bacteria.
Study subjects.
The patient samples were collected as part
of a multicenter study conducted in seven academic adult intensive care
units (ICUs) in France between March 1996 and November 1997. The
protocol was approved by the Institutional Review Board of Cochin
Hospital, Paris, France. Informed consents were obtained from control
subjects and patients or their relatives.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal
Infection
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/ mice were shown to be LPS
hyporesponsive as well (6). Binding of LPS to TLR4, via a
complex involving CD14 as well as MD-2, is thought to initiate a
signaling cascade that involves several kinases and accessory molecules
such as MyD88 and IRAK, leading eventually to a nuclear translocation
of transcription factors NF-
B and AP-1 (14). The binding
of these transcription factors is responsible for initiating cytokine
and chemokine expression subsequent to LPS exposure. Recently,
mutations in the TLR4 receptor at residues 299 and 399 were shown to be
associated with hyporesponsiveness to inhaled endotoxin in humans
(2). Furthermore, the Asp299Gly TLR4 mutation may increase
the risk to carriers of developing gram-negative septic shock (E. Lorenz, J. Mira, K. Frees, and D. Schwartz, submitted for
publication). However, TLR4 does not seem to be involved in mediating
the cellular response to gram-positive pathogens. TLR2, which is highly
homologous to TLR4, has been shown to mediate a response to LPS, albeit
to a lesser degree than TLR4. In fact, while TLR4/ mice
are unable to respond to LPS (6), TLR2/ mice
respond normally to LPS (16), indicating that TLR4 is the
main LPS receptor in mammals. More importantly, evidence suggests that
TLR2 is involved in the recognition of various other bacterial lipoproteins, such as peptides derived from Borrelia,
Mycoplasma, and Treponema (9). Still
more importantly, TLR2 has also been shown to be involved in
staphylococcus signaling (1, 3).
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) polymorphisms (11). An additional 31 healthy blood donors were included as control subjects for this study. The septic shock group, defined by the criteria of the consensus conference, included 91 ICU patients. Of these patients, 88 had been included in a
previously published study on the effect of TNF- on septic shock
(11), and 3 patients were included after June 1997.
acute deterioration of the patient's mental
status, arterial hypoxemia (PaO2/FiO2 < 280), plasma lactate
concentration above the normal range or metabolic acidosis, oliguria,
and disseminated intravascular coagulation. The exclusion criteria were
the following: (i) older than 80 years, (ii) cardiac failure (class III
or IV), (iii) liver insufficiency (Child C), (iv) bone marrow aplasia
(white blood cell count of <0.50 × 109/liter), or
(v) immunosuppression (positive human immunodeficiency virus serologic
result, current immunosuppressive therapy including corticosteroids
[equivalent prednisone, >0.5 mg/kg per day], or cancer).
Patients were monitored throughout their stays in the ICU. Information
on age, sex, primary site of infection, infection-related organisms,
and severity indexes (including the Simplified Acute Physiologic Score
[SAPS II] [8], which uses a total of 15 variables to
assess the severity of septic disease, and the Organ System Failure
score (OSF) [7]) was collected at each patient's
entry into the ICU. All the samples and information used in the study were coded, and patient confidentiality was preserved according to the
guidelines for studies of human subjects.
Mutation detection. Using single-stranded conformational polymorphism (SSCP), we initially screened the open reading frame of TLR2 in a population of 110 healthy volunteers at the University of Iowa. Genomic DNA was isolated from whole blood obtained from the study subjects using a rapid salt isolation procedure. Overlapping primer sets, less than 200 bp apart, were designed across the TLR2 coding sequence. Primers were derived from flanking intronic sequences to include all splice sites. Standard PCRs were prepared except that 10 to 20 ng of genomic DNA was used as a template. Amplification products were separated on nondenaturing, fan-cooled gels containing 5% acrylamide-bisacrylamide (19:1), 0.5× Tris-borate-EDTA (TBE), and 2.5% glycerol for 3 h at 20 W or 15 h at 5 W using standard procedures (17). The gels were subjected to silver staining, and aberrant bands were extracted from the gel, reamplified, and sequenced in both directions. To verify the sequence of the aberrant band, the same primers were used to amplify and sequence genomic DNA from each subject. TLR2 from at least one individual for which there was no aberrant band was also sequenced for comparison. The DNA sequence was determined with a Model 377 automated DNA sequencer (Perkin-Elmer, Norwalk, Conn.).
Sequencing of a human TLR2 cDNA plasmid to confirm the GenBank-submitted sequence showed the occurrence of an additional polymorphism at position 2251 of the open reading frame. This polymorphism results in an Arg (CGG) to a Gln (CAG) substitution. Subsequent sequencing of the control population showed that the G to A polymorphism, even though not detected by SSCP, occurred in 3% of the population. To determine the TLR2 genotype of the samples in both the Iowa test population and the French septic shock group with respect to the arginine to glutamine polymorphisms, the genomic DNA was amplified using forward primer 5'-TATGGTCCAGGAGCTGGAGA-3' and reverse primer 5'-TGACATAAAGATCCCAACTAGACAA-3', which span the region containing the polymorphism. PCR conditions were as follows: 5 min of initial denaturation at 95°C, followed by 30 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 1 min. Following PCR amplification, fragments were purified using the Qiagen gel purification kit and were sequenced. The sequence of the genomic DNA from each subject was determined using a Model 377 automated DNA sequencer (Perkin-Elmer). The sequence analysis was performed blinded to the phenotype of the study subjects.Mammalian cell culture and transfections.
293T cells were
plated at a density of 300,000 in a 35-mm2 dish the day
prior to the transfection. Transfections were performed using the
CalPhos optimizer kit from Clontech according to the manufacturer's
recommendation for 35-mm2 plates with 4 µg of DNA per
dish. Each DNA mix consisted of 2 µg of reporter plasmid and 1 µg
of each expression plasmid, replaced by an empty vector if only one
expression plasmid was being used. In addition, 0.1 µg of
-galactosidase reporter plasmid was added to the transfection mix as
an internal control for transfection efficiency. The transfection mix
was added dropwise to the cells and was incubated for 4 h at 5%
CO2. After the incubation, the transfection medium was
removed and fresh Dulbecco modified Eagle medium supplemented with 1%
fetal calf serum, 2 mM L-glutamine, and 10,000 U of
PenStrep/ml was added overnight. Cells were lysed the following day
using reporter lysis buffer (Promega, Madison, Wis.), and after
overnight incubation at 4°C, luciferase and protein assays were done.
Protein assay. Protein contents of the lysates were measured using the Bio-Rad protein assay reagent. In short, cells were lysed in 1× lysis buffer (Promega) overnight at 4°C. The following day, 1.2 µl of lysate was added to 200 µl of diluted Bio-Rad protein reagent, and the absorbance was read at 595 nm in a microplate reader from BioTek Instruments (Scotts Valley, Calif.). Each condition was assayed in triplicate, and the sample protein concentration was calculated based on known bovine serum albumin standards.
Luciferase assay. Luciferase assay reagents were purchased from Promega. Briefly, cells were lysed in 1× lysis buffer overnight at 4°C. For each assay, 8 µl of lysate was added to 100 µl of luciferase assay reagent and read in a Luminometer Model Monolight 2010 (Analytical Luminescence Laboratories, San Diego, Calif.).
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
A novel polymorphism in the human TLR2 gene causes an arginine to
glutamine substitution at the C terminus.
We used SSCP to screen
the open reading frame of the human TLR2 gene in the original Iowa test
population for possible point mutations. In each of three individuals,
we detected two silent polymorphisms (Table
1). No missense mutations were detected. When sequencing a TLR2 cDNA from a human cDNA library (gift of F. Gusovsky), we identified a sequence change at the 3' terminus of the
TLR2 gene. This sequencing change causes an arginine to glutamine
substitution at residue 753. Since the arginine is conserved between
mice and humans and is part of a highly conserved stretch of amino
acids at the C terminus of TLR2 (Fig. 1),
we screened a population of healthy blood donors. The TLR2 Arg753Gln
polymorphism occurred in 3% of the subjects tested.
|
|
TLR2 Arg753Gln polymorphism does not affect the LPS response in
vitro.
TLR2 wild-type (gift of S. Akira) and TLR2 Arg753Gln mutant
cDNAs were transfected into LPS unresponsive 293T cells, and NF-B activity was measured by luciferase assay. While at the same
concentration of LPS (100 ng/ml) TLR4 shows a more than twofold
stimulation by LPS 0111.B4, neither the wild-type TLR2 nor the TLR2
Arg753Gln mutant showed a significant stimulation of NF-B in
response to LPS 0111.B4 (Fig. 2). This
result suggests that the TLR2 Arg753Gln mutation does not affect the
ability of TLR2 to respond to LPS.
|
TLR2 Arg753Gln mutation affects the ability to respond to bacterial peptides in vitro. We next measured the ability of the TLR2 Arg753Gln mutation to mediate the cellular response to bacterial peptides. We used two artificial peptides (kind gift of T. Sellati, Department of Pathology, University of Connecticut Health Center, Farmington, Conn.): B. Burgdoferi-derived OspA and T. pallidum-derived 47L (13). Transfection of 293T cells with the plasmids described above and subsequent luciferase assays showed that the wild-type TLR2 cDNA gave about a 1.5- to 2-fold increase in response to both active peptides compared to a nonlipidated control peptide. The TLR2 Arg753Gln mutation, on the other hand, did not show any activation in response to these peptides, similar to previous results in a TLR2-deficient strain (16). This indicates that mutation of a conserved arginine to glutamine reduces the ability of TLR2 to respond to bacterial peptides in vitro.
TLR2 Arg753Gln mutation occurs in two patients with staphylococcal infections. Based on our in vitro data, we tested whether the TLR2 Arg753Gln mutation would occur in patients with gram-positive infection more commonly than in patients with gram-negative infections. In a well-characterized population of patients with septic shock, we found that the TLR2 Arg753Gln polymorphism occurred in 2 of the 91 septic shock patients. While only a minority of the septic shock patients had gram-positive infections (n = 22), both the patients heterozygous for the TLR2 Arg753Gln allele had staphylococcal infections. The presence of the TLR2 Arg753Gln mutation was higher in the patients with gram-positive septic shock (2 out of 22, or 9%) compared to all other patients with septic shock (0 out of 69, or 0%).
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
We report a novel polymorphism of the TLR2 gene that affects the response to bacterial peptides in vitro and may be associated with an increased risk for staphylococcal septic shock in patients with the mutation. The TLR2 Arg753Gln (G2251A) polymorphism has an allele frequency of about 3% in the populations tested and changes a highly conserved arginine residue to a glutamine. While the response to LPS is virtually unaffected, the response to peptides from B. burgdorferi and T. pallidum is lacking in cells carrying the TLR2 Arg753Gln polymorphism compared to that in wild type cells. Furthermore, screening of a septic shock population showed that the two patients with the TLR2 Arg753Gln polymorphism were diagnosed with staphylococcal infections. These results indicate that the TLR2 Arg753Gln polymorphism may place individuals at a higher risk for gram-positive septic shock. Because of the small sample size, we did not find a significant association between the TLR2 Arg753Gln polymorphism and an increased risk for gram-positive septic shock. While this may indicate that the association between the TLR2 polymorphism and gram-positive septic shock could be due to chance alone, previous in vitro results related to TLR2 function suggest that the lack of correlation is due to the small sample size and the rarity of the polymorphism.
TLR2 plays a unique role in innate immunity. While TLR4 seems to be
highly specific for LPS-mediated signaling (16), TLR2 can
respond to a variety of different bacterial cell wall components (9). Even though the homology between TLR2 and TLR4 is high, the proteins have different roles in the immune system. TLR2 has been
shown to respond to bacterial lipoproteins. While it can be activated
by lipoproteins derived from Borrelia, Treponema, and Staphylococcus (9). TLR2 is not universal for
gram-positive cell wall components. It cannot be activated by group B
type III streptococci (4). With respect to LPS, TLR4 seems
to be a major mammalian LPS receptor. While TLR2 has been shown to
respond to high doses of LPS in in vitro assays, it is not the main LPS
receptor in vivo, as studies in both TLR4/ and
TLR2/ mice have shown (6). The downstream
signaling pathway is shared between TLR2 and TLR4, involving MyD88 and
IRAK related proteins and resulting in activation of NF-B and AP-1.
Since TLR2 can respond to a variety of peptides derived from
gram-positive organisms, a mutation in TLR2 can affect the immune response to various bacterial stimuli and potentially place individuals at a significant risk for septic shock. Only 2 of the 22 patients with
gram-positive septic shock had the TLR2 Arg753Gln mutation. Since the
mutation is located at the very C terminus of TLR2, it likely affects
the signaling function of the molecule, rather than ligand binding. So
far no functional domains have been identified in human TLR2, but
potential functions of the C terminus include dimerization to form TLR2
homodimers or heterodimers with downstream targets such as MyD88. Since
the interleukin-1 (IL-1) receptor is highly homologous to the TLR2
protein, especially at the intracellular domain, evidence suggesting an
involvement of the IL-1 receptor C terminus in IL-1-mediated signaling
could indicate similar functions for the TLR2 C terminus
(15). The results in this paper may indicate that the C
terminus of TLR2 is involved in signaling and that Arg753,
specifically, is important for this receptor function. More research is
necessary to correlate mutations in TLR2 with functional consequences.
The fact that only 2 out of 22 patients with gram-positive sepsis were
carriers for the TLR2 mutation suggests that additional genes may be
involved in determining the susceptibility to septic shock for
gram-positive organisms. Mutations in additional genes, such as those
for TNF- (11) and TLR4 (E. Lorenz et al., submitted) have
been linked to septic shock susceptibility. We did not find any
evidence of linkage between the TLR2 Arg753Gln allele and these two
markers in this population. Most likely, a larger sample size is needed
because of the rarity of the TLR2 allele. It is therefore necessary to screen a variety of candidate genes, such as those for cytokines and
members of the TLR signaling pathway, to characterize the genetics of
septic shock susceptibility.
| |
ACKNOWLEDGMENTS |
|---|
We extend appreciation to Kathy Frees, Nicole Meyer, and Stephanie Swartz for their technical assistance.
This study was supported by grants from the Department of Veterans Affairs (Merit Review), the National Institute of Environmental Health Sciences (ES06537, ES07498, and ES09607), and the National Heart, Lung, and Blood Institute (HL62628).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Pulmonary and Critical Care Medicine, Duke University Medical Center, Research Dr., Room 275 MSRB, DUMC Box 2629, Durham, NC 27710. Phone: (919) 668-0380. Fax: (919) 668-0494. E-mail: david.schwartz{at}duke.edu.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. |
Aliprantis, A.,
R. Yang,
M. Mark,
S. Suggett,
B. Devaux,
J. Radolf,
G. Klimpel,
P. Godowski, and A. Zychlinsky.
1999.
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.
Science
285:736-739 |
| 2. | Arbour, N. C., E. Lorenz, B. Schutte, J. Zabner, J. Kline, M. Jones, K. Frees, J. L. Watt, and D. A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:187-191[CrossRef][Medline]. |
| 3. |
Brightbill, H.,
D. Libraty,
S. Krutzik,
R. Yang,
J. Belisle,
J. Bleharski,
M. Maitland,
M. Norgard,
S. Plevy,
S. Smale,
P. Brennan,
B. Bloom,
P. Godowski, and R. Modlin.
1999.
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
Science
285:732-736 |
| 4. |
Flo, T.,
O. Halaas,
E. Lien,
L. Ryan,
G. Teti,
D. Golenbock,
A. Sundan, and T. Espevik.
2000.
Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide.
J. Immunol.
164:2064-2069 |
| 5. |
Heine, H.,
C. Kirschning,
E. Lien,
B. Monks,
M. Rothe, and D. Golenbock.
1999.
Cutting edge: cells that carry a null allele for toll-like receptor 2 are capable of responding to endotoxin.
J. Immunol.
162:6971-6975 |
| 6. |
Hoshino, K.,
O. Takeuchi,
T. Kawai,
H. Sanjo,
T. Ogawa,
Y. Takeda,
K. Takeda, and S. Akira.
1999.
Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
J. Immunol.
162:3749-3752 |
| 7. | Knaus, W., E. Draper, and D. Wagner. 1989. Multiple systems organ failures: epidemiology and prognosis. Crit. Care Clin. 5:221-232[Medline]. |
| 8. |
Le Gall, J.,
S. Lemeshow, and F. Saulnier.
1993.
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.
JAMA
270:2957-2963 |
| 9. |
Lien, E.,
T. Sellati,
A. Yoshimura,
T. Flo,
G. Rawadi,
R. Finberg,
J. Carroll,
T. Espevik,
R. Ingalls,
J. Radolf, and D. Golenbock.
1999.
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.
J. Biol. Chem.
274:33419-33425 |
| 10. | Medzhitov, R., and C. A. Janeway. 1997. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:4-9[CrossRef][Medline]. |
| 11. |
Mira, J.,
A. Cariou,
F. Grall,
C. Delclaux,
M. Losser,
F. Heshmati,
C. Cheval,
M. Monchi,
J. Teboul,
F. Riche,
G. Leleu,
L. Arbibe,
A. Mignon,
M. Delpech, and J. Dhainaut.
1999.
Association of TNF2, a TNF- promoter polymorphism, with septic shock susceptibility and mortality.
JAMA
282:561-568 |
| 12. |
Poltorak, A.,
X. He,
I. Smirnova,
M.-Y. Liu,
C. Van Huffel,
X. Du,
D. Birdwell,
E. Alejos,
M. Silva,
C. Galanos,
M. Freudenberg,
P. Ricciardi-Castagnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/Hej and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science
282:2085-2088 |
| 13. |
Sellati, T.,
D. Bouis,
M. Caimano,
J. Feulner,
C. Ayers,
E. Lien, and J. Radolf.
1999.
Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins.
J. Immunol.
163:2049-2056 |
| 14. |
Shimazu, R.,
S. Akashi,
H. Ogata,
Y. Nagai,
K. Fukudome,
K. Miyake, and M. Kimoto.
1999.
MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4.
J. Exp. Med.
189:1777-1782 |
| 15. | Singh, R., B. Wang, A. Shirvaikar, S. Khan, S. Kamat, J. Schelling, M. Konieczkowski, and J. Sedor. 1999. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J. Clin. Investig. 103:1561-1570[Medline]. |
| 16. | Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451[CrossRef][Medline]. |
| 17. | Warren, W., E. Hovig, B. Smith-Sorensen, A. Borresen, F. Fujimura, Q. Liu, J. Feng, and S. Sommer. 1997. Detection of mutations by single-strand conformation polymorphism (SSCP) analysis and SSCP-hybrid methods, p. 7.41-7.43. In N. C. Dracopoli, J. L. Haines, B. R. Korf, D. T. Moir, C. C. Morton, C. E. Seidman, J. G. Seidman, and D. R. Smith (ed.), Current protocols in human genetics. John Wiley & Sons, Inc., New York, N.Y. |
Infection and Immunity, November 2000, p. 6398-6401, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Correale, J., Farez, M.
(2009). Helminth Antigens Modulate Immune Responses in Cells from Multiple Sclerosis Patients through TLR2-Dependent Mechanisms. J. Immunol.
183: 5999-6012
[Abstract] [Full Text] -
Highet, A R, Berry, A M, Goldwater, P N
(2009). Novel hypothesis for unexplained sudden unexpected death in infancy (SUDI). Arch. Dis. Child.
94: 841-843
[Abstract] [Full Text] -
Griesbeck-Zilch, B., Osman, M., Kuhn, Ch., Schwerin, M., Bruckmaier, R. H., Pfaffl, M. W., Hammerle-Fickinger, A., Meyer, H. H. D., Wellnitz, O.
(2009). Analysis of key molecules of the innate immune system in mammary epithelial cells isolated from marker-assisted and conventionally selected cattle. J DAIRY SCI
92: 4621-4633
[Abstract] [Full Text] -
Han, F., Yu, H., Tian, C., Li, S., Jacobs, M. R., Benedict-Alderfer, C., Zheng, Q. Y.
(2009). Role for Toll-Like Receptor 2 in the Immune Response to Streptococcus pneumoniae Infection in Mouse Otitis Media. Infect. Immun.
77: 3100-3108
[Abstract] [Full Text] -
Dessein, R, Gironella, M, Vignal, C, Peyrin-Biroulet, L, Sokol, H, Secher, T, Lacas-Gervais, S, Gratadoux, J-J, Lafont, F, Dagorn, J-C, Ryffel, B, Akira, S, Langella, P, Nunez, G, Sirard, J-C, Iovanna, J, Simonet, M, Chamaillard, M
(2009). Toll-like receptor 2 is critical for induction of Reg3{beta} expression and intestinal clearance of Yersinia pseudotuberculosis. Gut
58: 771-776
[Abstract] [Full Text] -
O'Neill, L. A. J., Bryant, C. E., Doyle, S. L.
(2009). Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer. Pharmacol. Rev.
61: 177-197
[Abstract] [Full Text] -
Yajima, T., Knowlton, K. U.
(2009). Viral Myocarditis: From the Perspective of the Virus. Circulation
119: 2615-2624
[Full Text] -
Mukherjee, S., Sarkar-Roy, N., Wagener, D. K., Majumder, P. P.
(2009). Signatures of natural selection are not uniform across genes of innate immune system, but purifying selection is the dominant signature. Proc. Natl. Acad. Sci. USA
106: 7073-7078
[Abstract] [Full Text] -
Mogensen, T. H.
(2009). Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses. Clin. Microbiol. Rev.
22: 240-273
[Abstract] [Full Text] -
Schwartz, D. A.
(2008). Translating the Genome. Am. J. Respir. Crit. Care Med.
178: 662-663
[Full Text] -
Nance, S. C., Yi, A.-K., Re, F. C., Fitzpatrick, E. A.
(2008). MyD88 is necessary for neutrophil recruitment in hypersensitivity pneumonitis. J. Leukoc. Biol.
83: 1207-1217
[Abstract] [Full Text] -
Humphreys, T. L., Li, L., Li, X., Janowicz, D. M., Fortney, K. R., Zhao, Q., Li, W., McClintick, J., Katz, B. P., Wilkes, D. S., Edenberg, H. J., Spinola, S. M.
(2007). Dysregulated Immune Profiles for Skin and Dendritic Cells Are Associated with Increased Host Susceptibility to Haemophilus ducreyi Infection in Human Volunteers. Infect. Immun.
75: 5686-5697
[Abstract] [Full Text] -
Hermann, C.
(2007). Review: Variability of host pathogen interaction. Innate Immunity
13: 199-218
[Abstract] -
Merx, S., Neumaier, M., Wagner, H., Kirschning, C. J, Ahmad-Nejad, P.
(2007). Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. Hum Mol Genet
16: 1225-1232
[Abstract] [Full Text] -
Chaudhuri, N., Whyte, M. K. B., Sabroe, I.
(2007). Reducing the Toll of Inflammatory Lung Disease. Chest
131: 1550-1556
[Abstract] [Full Text] -
Chang, J. H., Hampartzoumian, T., Everett, B., Lloyd, A., McCluskey, P. J., Wakefield, D.
(2007). Changes in Toll-like Receptor (TLR)-2 and TLR4 Expression and Function but Not Polymorphisms Are Associated with Acute Anterior Uveitis. IOVS
48: 1711-1717
[Abstract] [Full Text] -
Cheng, I., Plummer, S. J., Casey, G., Witte, J. S.
(2007). Toll-Like Receptor 4 Genetic Variation and Advanced Prostate Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
16: 352-355
[Abstract] [Full Text] -
den Hartog, J.E., Morre, S.A., Land, J.A.
(2006). Chlamydia trachomatis-associated tubal factor subfertility: immunogenetic aspects and serological screening. Hum Reprod Update
12: 719-730
[Abstract] [Full Text] -
Gautam, J. K., Ashish, , Comeau, L. D., Krueger, J. K., Smith, M. F. Jr.
(2006). Structural and Functional Evidence for the Role of the TLR2 DD Loop in TLR1/TLR2 Heterodimerization and Signaling. J. Biol. Chem.
281: 30132-30142
[Abstract] [Full Text] -
Lasker, M. V., Nair, S. K.
(2006). Intracellular TLR Signaling: A Structural Perspective on Human Disease. J. Immunol.
177: 11-16
[Abstract] [Full Text] -
Romics, L. Jr, Szabo, G., Coffey, J. C., Wang, J. H., Redmond, H. P.
(2006). The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases. Arch Surg
141: 595-601
[Abstract] [Full Text] -
Chang, J.-S., Huggett, J. F., Dheda, K., Kim, L. U., Zumla, A., Rook, G. A. W.
(2006). Myobacterium tuberculosis Induces Selective Up-Regulation of TLRs in the Mononuclear Leukocytes of Patients with Active Pulmonary Tuberculosis.. J. Immunol.
176: 3010-3018
[Abstract] [Full Text] -
Vincent, J.-L., Abraham, E.
(2006). The Last 100 Years of Sepsis. Am. J. Respir. Crit. Care Med.
173: 256-263
[Abstract] [Full Text] -
Mockenhaupt, F. P., Cramer, J. P., Hamann, L., Stegemann, M. S., Eckert, J., Oh, N.-R., Otchwemah, R. N., Dietz, E., Ehrhardt, S., Schroder, N. W. J., Bienzle, U., Schumann, R. R.
(2006). Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. USA
103: 177-182
[Abstract] [Full Text] -
Deering, R. P., Orange, J. S.
(2006). Development of a Clinical Assay To Evaluate Toll-Like Receptor Function. CVI
13: 68-76
[Abstract] [Full Text] -
Laine, M.L., Morre, S.A., Murillo, L.S., van Winkelhoff, A.-J., Pena, A.S.
(2005). CD14 and TLR4 Gene Polymorphisms in Adult Periodontitis. JDR
84: 1042-1046
[Abstract] [Full Text] -
Balloy, V., Si-Tahar, M., Takeuchi, O., Philippe, B., Nahori, M.-A., Tanguy, M., Huerre, M., Akira, S., Latge, J.-P., Chignard, M.
(2005). Involvement of Toll-Like Receptor 2 in Experimental Invasive Pulmonary Aspergillosis. Infect. Immun.
73: 5420-5425
[Abstract] [Full Text] -
Schroder, N. W. J., Diterich, I., Zinke, A., Eckert, J., Draing, C., Baehr, V. v., Hassler, D., Priem, S., Hahn, K., Michelsen, K. S., Hartung, T., Burmester, G. R., Gobel, U. B., Hermann, C., Schumann, R. R.
(2005). Heterozygous Arg753Gln Polymorphism of Human TLR-2 Impairs Immune Activation by Borrelia burgdorferi and Protects from Late Stage Lyme Disease. J. Immunol.
175: 2534-2540
[Abstract] [Full Text] -
Fournier, B., Philpott, D. J.
(2005). Recognition of Staphylococcus aureus by the Innate Immune System. Clin. Microbiol. Rev.
18: 521-540
[Abstract] [Full Text] -
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., Farley, M. M., the Active Bacterial Core Surveillance Program of,
(2005). Methicillin-Resistant Staphylococcus aureus Disease in Three Communities. NEJM
352: 1436-1444
[Abstract] [Full Text] -
Palmer, S. M., Burch, L. H., Trindade, A. J., Davis, R. D., Herczyk, W. F., Reinsmoen, N. L., Schwartz, D. A.
(2005). Innate Immunity Influences Long-term Outcomes after Human Lung Transplant. Am. J. Respir. Crit. Care Med.
171: 780-785
[Abstract] [Full Text] -
Schoneveld, A.H., Oude Nijhuis, M.M., van Middelaar, B., Laman, J.D., de Kleijn, D.P.V., Pasterkamp, G.
(2005). Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc Res
66: 162-169
[Abstract] [Full Text] -
O'Brien, G. C., Wang, J. H., Redmond, H. P.
(2005). Bacterial Lipoprotein Induces Resistance to Gram-Negative Sepsis in TLR4-Deficient Mice via Enhanced Bacterial Clearance. J. Immunol.
174: 1020-1026
[Abstract] [Full Text] -
Hartel, Ch., Finas, D., Ahrens, P., Kattner, E., Schaible, Th., Muller, D., Segerer, H., Albrecht, K., Moller, J., Diedrich, K., Gopel, W., for the Genetic Factors in Neonatology Study Group,
(2004). Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod
10: 911-915
[Abstract] [Full Text] -
Bornstein, S. R., Zacharowski, P., Schumann, R. R., Barthel, A., Tran, N., Papewalis, C., Rettori, V., McCann, S. M., Schulze-Osthoff, K., Scherbaum, W. A., Tarnow, J., Zacharowski, K.
(2004). Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc. Natl. Acad. Sci. USA
101: 16695-16700
[Abstract] [Full Text] -
Moore, C. E., Segal, S., Berendt, A. R., Hill, A. V. S., Day, N. P. J.
(2004). Lack of Association between Toll-Like Receptor 2 Polymorphisms and Susceptibility to Severe Disease Caused by Staphylococcus aureus. CVI
11: 1194-1197
[Abstract] [Full Text] -
Kumar, A., Zhang, J., Yu, F.-S. X.
(2004). Innate Immune Response of Corneal Epithelial Cells to Staphylococcus aureus Infection: Role of Peptidoglycan in Stimulating Proinflammatory Cytokine Secretion. IOVS
45: 3513-3522
[Abstract] [Full Text] -
Homma, T., Kato, A., Hashimoto, N., Batchelor, J., Yoshikawa, M., Imai, S., Wakiguchi, H., Saito, H., Matsumoto, K.
(2004). Corticosteroid and Cytokines Synergistically Enhance Toll-Like Receptor 2 Expression in Respiratory Epithelial Cells. Am. J. Respir. Cell Mol. Bio.
31: 463-469
[Abstract] [Full Text] -
FITNESS, J., FLOYD, S., WARNDORFF, D. K., SICHALI, L., MWAUNGULU, L., CRAMPIN, A. C., FINE, P. E. M., HILL, A. V. S.
(2004). LARGE-SCALE CANDIDATE GENE STUDY OF LEPROSY SUSCEPTIBILITY IN THE KARONGA DISTRICT OF NORTHERN MALAWI. Am J Trop Med Hyg
71: 330-340
[Abstract] [Full Text] -
Lorenz, E., Chemotti, D. C., Vandal, K., Tessier, P. A.
(2004). Toll-Like Receptor 2 Represses Nonpilus Adhesin-Induced Signaling in Acute Infections with the Pseudomonas aeruginosa pilA Mutant. Infect. Immun.
72: 4561-4569
[Abstract] [Full Text] -
Whitsett, J. A., Bachurski, C. J., Barnes, K. C., Bunn, P. A. Jr., Case, L. M., Cook, D. N., Crooks, D., Duncan, M. W., Dwyer-Nield, L., Elston, R. C., Fessler, M. B., Franklin, W. A., Friedman, N., Garcia, J. G. N., Geraci, M. W., Glasgow, C., Glasser, S. W., Hardie, W. D., Henning, L. M., Johnson, G. L., Kawkitinarong, K., Keith, R. L., Korfhagen, T. R., Leikauf, G. D., Liggett, S. B., Malcolm, K. C., Malkinson, A. M., Mariani, T. J., McDowell, S. A., McGraw, D. W., Medvedovic, M., Moss, J., Nogee, L. M., Nonas, S., Pacheco-Rodriguez, G., Palmer, L. J., Peters, D. G., Prows, D. R., Redline, S., Regev, A., Sartor, M. A., Schwartz, D. A., Silverman, E. K., Steagall, W. K., Stearman, R. S., Taveira-DaSilva, A., Tichelaar, J. W., Tomlinson, C. R., Tsukada, K., Weaver, T. E., Wert, S. E., Wesselkamper, S. C., Worthen, G. S., Xu, Y., Zerbe, L., Zhang, Y., Zhang, Y., Choi, A. M. K., Kaminski, N.
(2004). Functional Genomics of Lung Disease. Am. J. Respir. Cell Mol. Bio.
31: S1-S81
[Full Text] -
Ben-Ali, M., Barbouche, M.-R., Bousnina, S., Chabbou, A., Dellagi, K.
(2004). Toll-Like Receptor 2 Arg677Trp Polymorphism Is Associated with Susceptibility to Tuberculosis in Tunisian Patients. CVI
11: 625-626
[Abstract] [Full Text] -
Netea, M. G., van der Graaf, C., Van der Meer, J. W. M., Kullberg, B. J.
(2004). Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol.
75: 749-755
[Abstract] [Full Text] -
von Aulock, S., Schroder, N. W. J., Traub, S., Gueinzius, K., Lorenz, E., Hartung, T., Schumann, R. R., Hermann, C.
(2004). Heterozygous Toll-Like Receptor 2 Polymorphism Does Not Affect Lipoteichoic Acid-Induced Chemokine and Inflammatory Responses. Infect. Immun.
72: 1828-1831
[Abstract] [Full Text] -
Ogus, A.C., Yoldas, B., Ozdemir, T., Uguz, A., Olcen, S., Keser, I., Coskun, M., Cilli, A., Yegin, O.
(2004). The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur Respir J
23: 219-223
[Abstract] [Full Text] -
Doyle, S. E., O'Connell, R. M., Miranda, G. A., Vaidya, S. A., Chow, E. K., Liu, P. T., Suzuki, S., Suzuki, N., Modlin, R. L., Yeh, W.-C., Lane, T. F., Cheng, G.
(2004). Toll-like Receptors Induce a Phagocytic Gene Program through p38. JEM
199: 81-90
[Abstract] [Full Text] -
Imler, J.-L., Zheng, L.
(2004). Biology of Toll receptors: lessons from insects and mammals. J. Leukoc. Biol.
75: 18-26
[Abstract] [Full Text] -
Hertz, C. J., Wu, Q., Porter, E. M., Zhang, Y. J., Weismuller, K.-H., Godowski, P. J., Ganz, T., Randell, S. H., Modlin, R. L.
(2003). Activation of Toll-Like Receptor 2 on Human Tracheobronchial Epithelial Cells Induces the Antimicrobial Peptide Human {beta} Defensin-2. J. Immunol.
171: 6820-6826
[Abstract] [Full Text] -
Diterich, I., Rauter, C., Kirschning, C. J., Hartung, T.
(2003). Borrelia burgdorferi-Induced Tolerance as a Model of Persistence via Immunosuppression. Infect. Immun.
71: 3979-3987
[Abstract] [Full Text] -
Bochud, P.-Y., Hawn, T. R., Aderem, A.
(2003). Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling. J. Immunol.
170: 3451-3454
[Abstract] [Full Text] -
Melmed, G., Thomas, L. S., Lee, N., Tesfay, S. Y., Lukasek, K., Michelsen, K. S., Zhou, Y., Hu, B., Arditi, M., Abreu, M. T.
(2003). Human Intestinal Epithelial Cells Are Broadly Unresponsive to Toll-Like Receptor 2-Dependent Bacterial Ligands: Implications for Host-Microbial Interactions in the Gut. J. Immunol.
170: 1406-1415
[Abstract] [Full Text] -
Schmitt, C., Humeny, A., Becker, C.-M., Brune, K., Pahl, A.
(2002). Polymorphisms of TLR4: Rapid Genotyping and Reduced Response to Lipopolysaccharide of TLR4 Mutant Alleles. Clin. Chem.
48: 1661-1667
[Abstract] [Full Text] -
Lorenz, E., Patel, D. D., Hartung, T., Schwartz, D. A.
(2002). Toll-Like Receptor 4 (TLR4)-Deficient Murine Macrophage Cell Line as an In Vitro Assay System To Show TLR4-Independent Signaling of Bacteroides fragilis Lipopolysaccharide. Infect. Immun.
70: 4892-4896
[Abstract] [Full Text] -
Jacinto, R., Hartung, T., McCall, C., Li, L.
(2002). Lipopolysaccharide- and Lipoteichoic Acid-Induced Tolerance and Cross-Tolerance: Distinct Alterations in IL-1 Receptor-Associated Kinase. J. Immunol.
168: 6136-6141
[Abstract] [Full Text] -
Zarember, K. A., Godowski, P. J.
(2002). Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines. J. Immunol.
168: 554-561
[Abstract] [Full Text] -
Subramanian, G., Adams, M. D., Venter, J. C., Broder, S.
(2001). Implications of the Human Genome for Understanding Human Biology and Medicine. JAMA
286: 2296-2307
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»